Evidence-gap map · non-drug interventions

Epilepsy evidence gaps

349 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Epilepsy, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

349registered non-drug trials
28with results posted
70recruiting as of 2026-11-16
88group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Epilepsy by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (19)1·55·451 with results114245·31 with results·
Rehabilitation and therapy services (8)··22·····2·14·22
Breathing and respiratory training (2)········1··2····
Mind-body and psychological approaches (39)2·611141·114·310155
Cognitive training and education (30)··33·1···9··10·91 with results5
Diet, fasting and nutrition (34)··11·····31526·41
Sleep and circadian approaches (8)·····5······3··21 with results
Neuromodulation and electrical stimulation (85)··642 with results2·141 with results111 with results1273 with results4411 with results171 with results102 with results
Oxygen, light, temperature and manual therapies (6)2··1·2······4·1·
Supplements and nutraceuticals (35)·····32 with results·1···8181 with results·103
Other devices and digital tools (9)···21·2··1··5·22
Care delivery and health services (10)···3·····2··11 with results·42 with results2
Other behavioural, not yet classified (79)··132 with results201 with results2·1··101 with results·62 with results191 with results41 with results192 with results14

The table scrolls sideways: 16 outcome columns.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 30 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (54 trials of other approaches did).
  • Among the 10 trials of care delivery and health services found, none used inflammation and other biomarkers as a primary outcome (54 trials of other approaches did).
  • Among the 9 trials of other devices and digital tools found, none used inflammation and other biomarkers as a primary outcome (54 trials of other approaches did).
  • Among the 8 trials of sleep and circadian approaches found, none used inflammation and other biomarkers as a primary outcome (54 trials of other approaches did).
  • Among the 35 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (50 trials of other approaches did).
  • Among the 8 trials of sleep and circadian approaches found, none used mood, anxiety and wellbeing as a primary outcome (50 trials of other approaches did).
  • Among the 35 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (43 trials of other approaches did).
  • Among the 8 trials of sleep and circadian approaches found, none used quality of life as a primary outcome (43 trials of other approaches did).
  • Among the 35 trials of supplements and nutraceuticals found, none used cognition as a primary outcome (35 trials of other approaches did).
  • Among the 10 trials of care delivery and health services found, none used cognition as a primary outcome (35 trials of other approaches did).
  • Among the 9 trials of other devices and digital tools found, none used cognition as a primary outcome (35 trials of other approaches did).
  • Among the 8 trials of sleep and circadian approaches found, none used cognition as a primary outcome (35 trials of other approaches did).
  • Among the 85 trials of neuromodulation and electrical stimulation found, none used sleep as a primary outcome (17 trials of other approaches did).
  • Among the 34 trials of diet, fasting and nutrition found, none used sleep as a primary outcome (17 trials of other approaches did).

Questions studied but with no results posted

  • Diet, fasting and nutrition × symptom severity and disease activity: 26 trials registered, none with results posted (3 still recruiting)
  • Mind-body and psychological approaches × quality of life: 14 trials registered, none with results posted (2 still recruiting)
  • Mind-body and psychological approaches × mood, anxiety and wellbeing: 11 trials registered, none with results posted
  • Mind-body and psychological approaches × symptom severity and disease activity: 10 trials registered, none with results posted (1 still recruiting)
  • Cognitive training and education × symptom severity and disease activity: 10 trials registered, none with results posted
  • Supplements and nutraceuticals × feasibility, adherence and safety: 10 trials registered, none with results posted
  • Cognitive training and education × quality of life: 9 trials registered, none with results posted
  • Supplements and nutraceuticals × inflammation and other biomarkers: 8 trials registered, none with results posted (1 still recruiting)
  • Mind-body and psychological approaches × cognition: 6 trials registered, none with results posted (3 still recruiting)
  • Neuromodulation and electrical stimulation × cognition: 6 trials registered, none with results posted (2 still recruiting)
  • Exercise and physical activity × cognition: 5 trials registered, none with results posted
  • Exercise and physical activity × mood, anxiety and wellbeing: 5 trials registered, none with results posted
  • Exercise and physical activity × symptom severity and disease activity: 5 trials registered, none with results posted
  • Mind-body and psychological approaches × feasibility, adherence and safety: 5 trials registered, none with results posted

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Epilepsy

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 46 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.